Thanks to more comprehensive data entry, quick feedback times, and intuitive usability, IDBS’ E-WorkBook has helped Bayer achieve operational excellence across its laboratories, saving the business time and money.
Since introducing E-WorkBook, Bayer has decreased the lag times for experiments and increased the speed in which experiments can be completed by up to three hours. E-WorkBook has helped Bayer overcome a number of other common laboratory issues, such as quality of data entry and the speed feedback can be obtained, thanks to an easily accessible, user-friendly interface – ensuring all information is in one place, and in a consistent format.
Join our webinar with Oliver Hesse (Director Lab Automation and Data Management, Bayer Healthcare LLC) and Will Scott (Senior Consultant, IDBS) to find out how Bayer is continuing to use E-WorkBook to improve lab practices, increase laboratory efficiency and build a laboratory environment suited for business needs both now and in the future.
This webinar will include:
- Examples of how E-WorkBook has improved laboratory practices for Bayer on a day-to-day basis with real-life case studies
- Explain how Bayer managed the roll-out process of the new technology
- Explore what laboratory improvements Bayer can expect to see in future thanks to the advancement of technologies, such as laboratory automation
E-WorkBook is used by 22 of the top 25 pharmaceutical companies around the world, serving over 50,000 researchers in over 25 countries. Sign up for the webinar today to learn about how you can join them.
Oliver Hesse, Director Lab Automation & Data Management, Bayer Healthcare
Oliver Hesse is Director for Lab Automation & Data Management at Bayer – Biological Development in Berkeley, CA. He started his career in small biotech, building up and running high throughput screening systems for large molecules that generated large amounts of data and incorporated automated decision making. Since 2008 he has been at Bayer and since 2011 at the Berkeley site. There he is developing and implementing strategies and directs projects with respect to lab automation, lab informatics and data sciences for the global biological development organization with the goal to not only increase the operational efficiency of the organization but specifically also increase the ‘scientific efficiency’.
Who Should Attend?
Senior scientists and laboratory professionals in the pharmaceutical, biotechnological, and healthcare industry.
IDBS is a leading global provider of advanced software for research and development (R&D) organizations to securely capture, manage, share and exploit structured and unstructured data. We create cloud-based solutions that are designed to meet the challenges faced by organizations and their scientists with scientific data management and lab informatics. We enable our customers around the world to get back to what they do best: science. We believe our technology and solutions have the power to help leading organizations, and their people, solve some of the world’s biggest challenges. Our drive for simplicity and innovation ensures we lead the way and transform R&D worldwide. Our customers around the globe trust us with their data, their business and their success. And our diverse customer list includes R&D-driven international companies in pharmaceuticals, biotechnology, agricultural sciences, chemicals, consumer goods, energy, engineering, food and beverage, and healthcare.
Founded in 1989 and privately held, IDBS is headquartered in the United Kingdom with offices across Europe, Asia and the United States. IDBS remains a privately held company employing over 250 staff across the world and serving over 50,000 researchers in 25 countries – including over 75% of the top twenty pharmaceutical companies.
Bayer Healthcare LLC
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our Research and Development activities are based on a profound understanding of the biochemical processes in living organisms. The Pharmaceuticals Division focuses on prescription products, especially for women’s healthcare and cardiology, and also on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the Radiology Business Unit which markets contrast-enhanced diagnostic imaging equipment together with the necessary contrast agents.